Coronary Stents Market size is anticipated to surpass USD 9.3 billion by 2032, according to a new research report by Global Market Insights Inc.
Rising prevalence of cardiovascular disease (CVD) among the elderly population will drive the demand for coronary stents in the years to come. According to the World Health Organization (WHO) report, there were around 1 billion people worldwide aged over 60 years and above in 2019. The agency added that these figures are estimated to reach 1.4 billion people by 2030, and 2.1 billion by 2050.
Chronic diseases including percutaneous coronary intervention and peripheral vascular treatments are more common in geriatric people. Adoption of a sedentary lifestyle and unhealthy eating habits could elevate the cases of heart diseases, thereby boosting gains for coronary stents.
Rise in cases of deep vein thrombosis (DVT) in the US
Coronary stents market share from the bioresorbable vascular scaffold (BVS) segment is expected to record more than 5.2% CAGR by 2032. Bioresorbable vascular scaffolds improve aberrant endothelial function, lessen complications including thrombosis and inflammation, and restore normal vasomotion. Elevated cases of deep vein thrombosis could have a positive impact on segment growth.
Based on data from the CDC, nearly 900,000 people could be affected by deep vein thrombosis (DVT) each year in the United States. Gaining popularity and preference for minimally invasive procedures and rising elderly population in the country may further drive product uptake.
Robust demand for coronary stents across hospitals
Coronary stents market from the hospitals segment held more than 39% share in 2022. Coronary stents are crucial tools that are frequently utilized in a variety of minimally invasive surgical procedures done across hospitals. The revenue in hospitalization rate has reinforced the value for these stents for treating CVD-related illnesses.
The increasing stress levels contribute to multiple diseases like high blood pressure, heart diseases, and more driving hospital admissions. The increased implementation and use of coronary stents in hospital settings will influence market development.
Browse key industry insights spread across 170 pages with 260 market data tables & 10 figures & charts from the report, “Coronary Stents Market Size By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By End-use (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” In detail along with the table of contents:
High prevalence of heart disease across Europe
Europe coronary stents market is expected to reach USD 855 million by 2032. Cases of heart disease and other related ailments have increased significantly across European countries in recent years. As per a British Heart Foundation study, in 2022, nearly 7.6 million people in the United Kingdom are suffering from heart disease. The study estimates that more than half the population of the UK will be affected by heart or circulatory disease in their lifetime. This is predicted to drive the progress for coronary stents in the region.
Coronary stents companies focusing on products developments
Biotronik SE & Co. KG, Meril Life Science, Boston Scientific Corporation, Elixir Medical Corporation, Abbott Laboratories, Medtronic Plc, Terumo Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, and Biosensors International Group are some of the key players in the global coronary stents market.